Søgning på udtrykket 'covid' giver 79 resultater


Dokumenter [7] Sider [2] Kalender [29] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]

Dokumenter [7]

Dette notat omfatter patienter med følger efter infektion med SARS-CoV-2. Aktuelt defineres vedvarende symptomer ≥4 uger efter infektionsstart som langvarige symptomer, og vedvarende symptomer ≥12 uger anses som senfølger efter COVID-19.

Denne vejledning er tiltænkt diagnostik og behandling af COVID-19. Denne retningslinje vil løbende blive opdateret, som ny evidens kommer frem. Der er ikke foretaget en gradering af evidensniveau. Ændringer i denne udgave: Remdesivir står ikke længere som relativt kontraindiceret ved påvirket nyrefunktion.

Invitation til møde den 20. maj 2022

COVID-19 pandemien: Erfaringer vedrørende migranter og etniske minoriteters sundhed

DSI anbefaler fortsat remdesivir ved indlæggelsekrævende COVID-19 med behov for tilskud af ilt, hvor iltmætningen i blodet er under 94% uden ilttilskud hos ellers lungeraske og, at hvor der ved røntgen af thorax påvises infiltrat(er). Dette holdningspapir omhandler baggrunden for anbefalingen.

Indlæg af formand Rikke Krogh-Madsen i Altinget om opgradering af det infektionsmedicinske speciale

Vurdering af behov for antivirale midler og effekt af SARS-CoV2 infektion i de risikogrupper, som ifølge gældende retningslinjer skal tilbydes behandling med lægemidlet.

Sider [2]

… Borrelia: Anne-Mette Lebech (tovholder), Christian Brandt, Fredrikke Christie Knudtzen, Helene Mens, Jacob Bodilsen, Sigurdur Skarphédinsson Borrelia klaringsrapport (2014), Diagnostik og behandling af Lyme neuroborreliose (2021), COVID-19: Michael Dalager-Pedersen (tovholder), Marie Helleberg, Gitte Kronborg, Isik Somuncu, Merete Storgaard, Lothar Wiese COVID-19 retningslinje (2023v26), Cystisk fibrose (SST's arbejdsgruppe til eftersyn af området vedrørende cyst…

Professor Henrik Nielsen kommenterer: Så kom den endelig. Længe ventet, med spænding imødeset. Fagfællebedømt artikel om BioNTech/Pfizers BNT162b2 mRNA vaccine mod COVID-19. Selvfølgelig i NEJM og naturligvis af stor aktuel interesse, men vil også blive stående som en klassiker i medicinsk litteratur. En milepæl i vaccinologiens historie, blandt andet fordi der er anvendt en ny teknologisk platform og fordi studiet er kommet i mål på rekordtid. Alle infektionsmedicinere bør kende denne publikat…


Kalender [29]

14. december 2022, Online
11. oktober 2022, Online
20. maj 2022, Aarhus Universitet
21. marts 2022, Aarhus Universitetshospital, Skejby
9. februar 2022, Online
4. januar 2022, Online
7. december 2021, Online
4. november 2021, Online
21. september 2021, Online
31. august 2021, Holst Auditoriet, Mærsk Tårnet, København
16. juni 2021, Online
27. maj 2021, Online
7. maj 2021, Online
13. april 2021, Online
23. marts 2021, Online
22. marts 2021, Online
16. marts 2021, Online
3. februar 2021, Online
19. januar 2021, Online
30. december 2020, Online
9. oktober 2020, Århus og online
18. juni 2020, Aflyst på grund af COVID-19
3. juni 2020, Mødet udskudt på grund af COVID-19
24. marts 2020, København

Nyt fra tidsskrifterne [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
BMJ Open
10.12.2023
. Objectives. The study aim was to evaluate vaccine effectiveness (VE) of COVID-19 vaccines in preventing symptomatic COVID-19 among healthcare workers (HCWs) in Zambia. We sought to answer the question, ‘What is the vaccine effectiveness of a complete schedule of the SARS-CoV-2 vaccine in preventing symptomatic COVID-19 among HCWs in Zambia?’ . Design/setting. We conducted a test-negative case–control study among HCWs across different levels of health facilities in Zambia offering point of care test…
BMJ Open
10.12.2023
. Objective. Despite advancement in vaccines and treatments for COVID-19 over the past 2 years, many concerns remain about reinfection and waning immunity against COVID-19 and its variants, especially among people with substance use disorder (SUD). The study assessed the risk of COVID-19 reinfection and severe illness among adults with SUD and their vaccination status to inform management in this vulnerable population as the pandemic continues. . Design. Retrospective cohort study. . Setting. Nationwide e…
BMJ Open
10.12.2023
…cluded physical distancing, closure of schools and businesses, restrictions on public gatherings and mandating the use of face masks among others. In the absence of widely available vaccinations, NPIs were the only known means to try to slow the spread of COVID-19. While numerous studies have assessed the effectiveness of these NPIs in high-income countries, less is known about the processes that lead to the adoption of policies and the factors that influence their implementation and adherence in low-income…
Clinical Microbiology and Infection
9.12.2023
To compare COVID-19-associated pulmonary mucormycosis (CAPM) with COVID-19-associated rhino-orbital mucormycosis (CAROM), ascertain factors associated with CAPM among patients with COVID-19, and identify factors associated with 12-week mortality in CAPM.
BMJ Open
9.12.2023
. Objectives. The aim of this multicentre COVID-PREDICT study (a nationwide observational cohort study that aims to better understand clinical course of COVID-19 and to predict which COVID-19 patients should receive which treatment and which type of care) was to determine the association between atrial fibrillation (AF) and mortality, intensive care unit (ICU) admission, complications and discharge destination in hospitalised COVID-19 patients. . Setting. Data from a historical cohort study in eight hospit…
BMJ Open
9.12.2023
. Objective. On 20 July 2021, after the outbreak of COVID-19 at Nanjing Lukou International Airport, several universities started closed management and online teaching. This had a large impact on students’ daily life and study, which may lead to mental health problems. The purpose of this study is to study the effect of screen time on mental health status of university students and the possible mediating effect of sleep status. . Methods. This was a cross-sectional study. A web-based questionnaire survey…
BMJ Open
9.12.2023
. Introduction. Non-invasive ventilation (NIV) treatment combined with pronation in patients with COVID-19 respiratory failure has been shown to be effective in improving respiratory function and better patient outcomes. These patients may experience discomfort or anxiety that may reduce adherence to treatment. . Objective. The aim of this study was to explore and describe the subjective experiences of patients undergoing helmet NIV and pronation during hospitalisation for COVID-19 respiratory failure, wit…
BMJ Open
9.12.2023
. Objectives. The aim of this study was to understand how patients experienced hypertension management, with or without blood pressure (BP) telemonitoring, during the COVID-19 pandemic. . Design, methods, participants and setting. This qualitative study conducted between April and November 2022 consisted of 43 semistructured telephone interviews (23 men and 20 women) from 6 primary care practices in one area of Scotland. . Results. From the views of 25 participants with experience of using the Connect Me …
BMC Infectious Diseases
9.12.2023
… antimicrobial and anti-inflammatory fluid that has been used to treat various pro-inflammatory conditions. In a feasibility study, we have previously demonstrated that hAF could be safely administered to severely ill patients with coronavirus disease-19 (COVID-19). The impact of acellular hAF on markers of systemic inflammation and clinical outcomes during COVID-19 infection remain unknown. . . . Objective. To determine th…
PLoS One Infectious Diseases
9.12.2023
by Byeong Yeob Choi, Abigail R. Grace, Jack Tsai . Few studies have examined heterogeneous associations of risk factors with Coronavirus Disease-2019 (COVID-19) symptoms by type. The objectives of this study were to estimate the prevalence of and risk factors associated with COVID-19 symptoms and to investigate whether the associations differ by the type of symptoms. This study obtained longitudinal data over 6 months from laboratory-confirmed COVID-19 cases in a citywide sample in San Antonio. Sixteen sym…
BMC Infectious Diseases
8.12.2023
… antimicrobial and anti-inflammatory fluid that has been used to treat various pro-inflammatory conditions. In a feasibility study, we have previously demonstrated that hAF could be safely administered to severely ill patients with coronavirus disease-19 (COVID-19). The impact of acellular hAF on markers of systemic inflammation and clinical outcomes during COVID-19 infection remain unknown. . . . Objective. To determine th…
BMC Infectious Diseases
8.12.2023
. Abstract. . Background. Amid the COVID-19 pandemic, extensive testing was undertaken by independent clinical laboratories (ICLs), yet limited research exists on this matter. Drawing from Green Cross Laboratories (GC Labs)' pandemic response experience, this study seeks to offer insights for preparation for the next pandemic. . . . Methods. …
BMC Infectious Diseases
8.12.2023
… The neurological symptoms caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are of increasing concern. Convulsions are among the main neurological manifestations reported in children with coronavirus disease-2019 (COVID-19), and cause serious harm to physical and mental health. This study aimed to investigate the risk factors for convulsion in children with COVID-19. . . . Methods. …
Lancet Infectious Diseases
8.12.2023
Treatment with SIM01 alleviates multiple symptoms of PACS. Our findings have implications on the management of PACS through gut microbiome modulation. Further studies are warranted to explore the beneficial effects of SIM01 in other chronic or post-infection conditions.
PLoS One Infectious Diseases
8.12.2023
by Arsenio De La Vega Sánchez, Ana Navas Pérez, Marcos Pérez-Carrasco, María Torrens Sonet, Yolanda Diaz Buendia, Patricia Ortiz Ballujera, Miguel Rodríguez López, Joan Sabater Riera, Aitor Olmo-Isasmendi, Ester Vendrell Torra, María Álvarez García-Pumarino, Mercedes Ibarz Villamayor, Rosa María Catalán Ibars, Iban Oliva Zelaya, Javier Pardos Chica, Conxita Rovira Anglès, Teresa M. Tomasa-Irriguible, Anna Baró Serra, Edward J. Casanova, Francisco J. González De Molina, on behalf of The AKICOV …
BMJ Open
8.12.2023
. Objectives. We aimed to provide a region-wide comprehensive account of the indirect effects of COVID-19 on patients with chronic disease, in terms of non-COVID-19 mortality, and access to both inpatient and outpatient health services over a 2-year pandemic period. . Design. Population-based retrospective study. . Setting. Adult patients, affected by at least 1 of 32 prevalent chronic conditions, residing in the Emilia-Romagna Region in Italy, during the years 2020 (N=1 791 189, 47.7% of the overall adul…
BMJ Open
8.12.2023
. Background. People with type 2 diabetes (T2D) are at increased risk of poor outcomes from COVID-19. Vaccination can improve outcomes, but vaccine hesitancy remains a major challenge. We examined factors influencing COVID-19 vaccine uptake among people with T2D in two sub-Saharan Africa countries that adopted different national approaches to combat COVID-19, Kenya and Tanzania. . Methods. A mixed-methods study was conducted in February-March 2022, involving a survey of 1000 adults with T2D (500 Kenya; 500…
Journal of Medical Virology
7.12.2023
Journal of Medical Virology, Volume 95, Issue 12, December 2023.
Journal of Medical Virology
7.12.2023
Journal of Medical Virology, Volume 95, Issue 12, December 2023.

Aktuelle smitsomme sygdomme [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
Medscape Infectious Diseases
9.12.2023
The Home Test to Treat program is virtual and offers at-home rapid tests, telehealth sessions, and at-home treatments to people nationwide. . WebMD Health News
Medscape Infectious Diseases
8.12.2023
The percentage of patients with a U09.9 diagnostic code in the year after a SARS-CoV-2 infection ranged from less than 4% in one region to more than 24% in another . Medscape Medical News
Medscape Infectious Diseases
7.12.2023
'A significant wave [of JN.1] has started here and could be blunted with a high booster rate and mitigation measures.' . WebMD Health News
Medscape Infectious Diseases
7.12.2023
Though many people remain on the fence about getting the latest COVID vaccine booster, new research suggests a strong argument for getting the shot this winter. . Medscape Medical News
Medscape Infectious Diseases
6.12.2023
Patients residing in nursing homes may exhibit signs of long COVID that are missed. . Medscape Medical News
Medscape Infectious Diseases
6.12.2023
COVID-19 appears to be heading for a holiday season increase across most of the United States. . WebMD Health News
Medscape Infectious Diseases
1.12.2023
Two doses of an mRNA COVID-19 vaccine reduced hospitalizations and emergency department visits by 40%. . Medscape Medical News
Medscape Infectious Diseases
1.12.2023
Researchers suggest this provides further evidence of benefit of SARS-CoV-2 vaccination before or during pregnancy. . Medscape Medical News
Eurosurveillance latest updates
1.12.2023
. Background. Understanding the relative vaccine effectiveness (rVE) of new COVID-19 vaccine formulations against SARS-CoV-2 infection is a public health priority. A precise analysis of the rVE of monovalent and bivalent boosters given during the 2022 spring-summer and autumn-winter campaigns, respectively, in a defined population remains of interest. . . Aim. We assessed rVE against hospitalisation for the spring-summer (fourth vs third monovalent mRNA vaccine doses) and autumn-winter (fifth BA.1/ancestr…
Morbidity and Mortality Weekly Report (MMWR)
1.12.2023
This report describes the effectiveness of COVID-19 mRNA vaccines among infants and children aged 6 months-4 years.
ECDC COVID-19 updates
30.11.2023
This report presents pooled COVID-19 vaccine effectiveness (VE) estimates for the first, second and third booster doses, against hospitalisation due to COVID-19 and COVID-19 related deaths in resident populations ≥50 years of age, living in the community.
Medscape Infectious Diseases
30.11.2023
The findings demonstrate how vaccine-induced T-cell responses could potentially reduce COVID-19 severity, the authors write. . Medscape Medical News
Medscape Infectious Diseases
30.11.2023
An emerging variant of COVID-19 called BA.2.86 that caused alarm earlier this summer has landed on the CDC's radar again. . WebMD Health News
Medscape Infectious Diseases
30.11.2023
Researchers have pinpointed a potential common link to the varying symptoms of long COVID and specific testing could solve the mystery. . Medscape Medical News
Eurosurveillance latest updates
24.11.2023
. Introduction. Two large multicentre European hospital networks have estimated vaccine effectiveness (VE) against COVID-19 since 2021. . . Aim. We aimed to measure VE against PCR-confirmed SARS-CoV-2 in hospitalised severe acute respiratory illness (SARI) patients ≥ 20 years, combining data from these networks during Alpha (March–June)- and Delta (June–December)-dominant periods, 2021. . . Methods. Forty-six participating hospitals across 14 countries follow a similar generic protocol using t…
Eurosurveillance latest updates
24.11.2023
. Introduction. The I-MOVE-COVID-19 and VEBIS hospital networks have been measuring COVID-19 vaccine effectiveness (VE) in participating European countries since early 2021. . . Aim. We aimed to measure VE against PCR-confirmed SARS-CoV-2 in patients ≥ 20 years hospitalised with severe acute respiratory infection (SARI) from December 2021 to July 2022 (Omicron-dominant period). . . Methods. In both networks, 46 hospitals (13 countries) follow a similar test-negative case–control protocol. We defin…
Eurosurveillance latest updates
24.11.2023
We followed 4,081,257 Australian adults aged ≥ 65 years between November 2022 and May 2023 for COVID-19-specific mortality, when recombinant SARS-CoV-2 Omicron lineages (predominantly XB and XBB) as well as BA.2.75 were circulating. Compared with a COVID-19 booster targeting ancestral SARS-CoV-2 given > 180 days earlier, the relative vaccine effectiveness against COVID-19 death of a bivalent (ancestral/BA.1 or ancestral/BA.4-5) booster given 8 to 90 days earlier was 66.0% (95%CI: 57.6 …
Morbidity and Mortality Weekly Report (MMWR)
23.11.2023
This report describes increases in cases of congenital syphilis during the COVID-19 pandemic.
Medscape Infectious Diseases
22.11.2023
A Mayo Clinic study found nearly 90% of patients with long COVID experience chest pain, but treatment for this condition is not yet standardized. . Medscape Medical News
Medscape Infectious Diseases
18.11.2023
'This entire year has been really filled with patients that have been trying to get access to the clinic for a year. And they’re still struggling.' . Medscape Medical News

Nyhedsbrev

Skriv din email adresse og modtag nyheder om hjemmesiden.


© 2023 Dansk Selskab for Infektionsmedicin

CVR: 33634307

infmed.dk
Version: 2.12.1
PHP version: 8.0.30
Design: Christian Philip Fischer
Side indlæst på 0.697 s

Cookies og privatliv